Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
11:58
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 15th Annual Conference

 

September 2 - 5, 2021 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 15th Annual Conference
    Topic - 5. Clinical Trials in progress

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 34
Visits: 82
Title: Sorafenib in extended patient populations in real-world clinical practice: Baseline characteristics from OPTIMIS and GIDEON
Authors: Masatoshi Kudo ,
Centre: 

You must be registered to reply or comment.

SORAFENIB IN EXTENDED PATIENT POPULATIONS IN REAL-WORLD CLINICAL PRACTICE: BASELINE CHARACTERISTICS FROM OPTIMIS AND GIDEON

Masatoshi Kudo
Thread initiator
Subspeciality
Reg: 8/27/2021 5:46:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 8/27/2021 5:46:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 215
Title: Temporal and Spatial Dynamics of Hepatic Stellate Cell Activation in Intrahepatic Cholangiocarcinoma
Authors: Liqin Zhu , Cheng Tian, Liyuan Li, Qingfei Pan, Yizhen Li, Wentao Yang, Li Fan, Anthony Brown, Michelle Morrison, Kaushik K. Dey, Eric J. Norris, Jun J. Yang, Jiyang Yu, Evan S. Glazer
Centre: 

Poster most viewed in this topic
Poster: 34
Visits: 82
Title: Sorafenib in extended patient populations in real-world clinical practice: Baseline characteristics from OPTIMIS and GIDEON
Authors: Masatoshi Kudo ,
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert